Paper7542476
A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine selectively activates chloride efflux from human epithelial and mouse fibroblast cell lines expressing the cystic fibrosis transmembrane regulator delta F508 mutation.
Guay-Broder C and 9 others. Biochemistry, 1995. Cited by 47 papers, by iCite.
Cite this record
ConductScience Library. A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine selectively activates chloride efflux from human epithelial and mouse fibroblast cell lines expressing the cystic fibrosis transmembrane regulator delta F508 mutation. Papers, record 7542476. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7542476
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine selectively activates chloride efflux from human epithelial and mouse fibroblast cell lines expressing the cystic fibrosis transmembrane regulator delta F508 mutation.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chlorides | Major topic |
| Membrane Proteins | Major topic |
| Purinergic P1 Receptor Antagonists | Major topic |
| Xanthines | Major topic |
| Animals | |
| Cell Line | |
| Cystic Fibrosis | |
| Cystic Fibrosis Transmembrane Conductance Regulator | |
| Humans | |
| Ion Transport | |
| Mice | |
| Mutation | |
| Potassium |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 HL047122 | NHLBI NIH HHS | United States | R01HL047122 | PubMed and NIH | NIH RePORTER |
| Z01 DK031127 | Intramural NIH HHS | United States | Z01DK031127 | PubMed | NIH RePORTER |
| Z99 DK999999 | Intramural NIH HHS | United States | Z99DK999999 | PubMed | NIH RePORTER |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39741902 | Adenosine A1 and A3 Receptors: Distinct Cardioprotection. | Drug Dev Res | 2001 | https://conductscience.org/library/papers/39741902 | PubMed |
| 23818513 | Cystic fibrosis transmembrane regulator correctors and potentiators. | Cold Spring Harb Perspect Med | 2013 | https://conductscience.org/library/papers/23818513 | PubMed |
| 20226262 | DeltaF508 CFTR processing correction and activity in polarized airway and non-airway cell monolayers. | Pulm Pharmacol Ther | 2010 | https://conductscience.org/library/papers/20226262 | PubMed |
| 17876495 | Characterization of a 7,8-benzoflavone double effect on CFTR Cl(-) channel activity. | J Membr Biol | 2007 | https://conductscience.org/library/papers/17876495 | PubMed |
| 15963954 | Amphiphilic pyridinium salts block TNF alpha/NF kappa B signaling and constitutive hypersecretion of interleukin-8 (IL-8) from cystic fibrosis lung epithelial cells. | Biochem Pharmacol | 2005 | https://conductscience.org/library/papers/15963954 | PubMed |
| 15136726 | Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cells. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15136726 | PubMed |
| 14993338 | Pharmacogenomics of cystic fibrosis. | Mol Interv | 2001 | https://conductscience.org/library/papers/14993338 | PubMed |
| 12464661 | Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis. | J Clin Invest | 2002 | https://conductscience.org/library/papers/12464661 | PubMed |
| 11606326 | Phenanthrolines--a new class of CFTR chloride channel openers. | Br J Pharmacol | 2001 | https://conductscience.org/library/papers/11606326 | PubMed |
| 10656877 | Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis. | Mol Med | 1999 | https://conductscience.org/library/papers/10656877 | PubMed |
| 10607860 | Adenosine and ischemic preconditioning. | Curr Pharm Des | 1999 | https://conductscience.org/library/papers/10607860 | PubMed |
| 10021451 | Novel pharmacologic therapies for cystic fibrosis. | J Clin Invest | 1999 | https://conductscience.org/library/papers/10021451 | PubMed |
| 9511934 | Strategies for correcting the delta F508 CFTR protein-folding defect. | J Bioenerg Biomembr | 1997 | https://conductscience.org/library/papers/9511934 | PubMed |
| 9488705 | Direct activation of cystic fibrosis transmembrane conductance regulator channels by 8-cyclopentyl-1,3-dipropylxanthine (CPX) and 1,3-diallyl-8-cyclohexylxanthine (DAX). | J Biol Chem | 1998 | https://conductscience.org/library/papers/9488705 | PubMed |
| 9135274 | delta F508 in cystic fibrosis: willing but not able. | Arch Dis Child | 1997 | https://conductscience.org/library/papers/9135274 | PubMed |
| 7543243 | CPX, a selective A1-adenosine-receptor antagonist, regulates intracellular pH in cystic fibrosis cells. | Am J Physiol | 1995 | https://conductscience.org/library/papers/7543243 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CFTR | 1080 | PubTator's text mining | https://conductscience.org/library/genes/1080 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7542476
GET https://conductscience.org/api/papers/v1/7542476/authors